Bio International Convention – Boston 23

Bio International Convention – Boston 23


Our CEO will be attending the BIO International in Boston from June 5th to 8th.

Cancerappy is dedicated to the discovery and development of new AI-based pharmaceuticals. Currently, we have a strong pipeline that validates and demonstrates our value proposition.

If you want to learn more about Cancerappy, feel free to find us at booth 7 in the Spain Pavilion.

Catálogo expositores ICEX

More about Bio Convention:





CancerAppy is pleased to announce that some new applications are now available in their proprietary platform.

One of them is the GeneReport tool, a personalized treatment matched application, that permits score predicted treatments with patient genomic actionable information.

Oncologists and physicians involved in cancer care, can easily match genomic information from patients with therapeutic options given alone or in combination. GeneReport provides the full information that a healthcare provider need to know to offer the maximum quality care.

GeneReport can reduce time, increase accuracy and help to select the best therapeutic options from all FDA approved drugs independently of the type of cancer, based on the patient genomic information. It is a necessary tool for physician teams involved in the treatment decision-making process of cancer patients. 

Request a sample 

Meet Sarah…

Meet Sarah…

Meet Sarah.
She’s a scientist who does research on medications that treat cancer. Now Sarah’s a busy woman, so she doesn’t have the 21 hours a day it would take to read and process all the new information that comes out about cancer everyday.

But luckily for Sarah, we’ve got a solution for that: CANCERAPPY.

Cancerappy analyzes, organizes, and synthesizes all the information a cancer researcher needs, providing a holistic vision and saving valuable time and resources. 
Cancerappy works because we created our own algorithm using artificial intelligence and these are things it gives us:

-Health Care Solutions
-Best Personalized Treatment
-Optimal drug development

Cancerappy provides unique value through the precise metrics it offers through big data and artificial intelligence which helps oncology professionals like Sarah make better decisions, save time, and increase the quality of care for any cancer patient.